Target intelligence / Profile preview

Stratum Corneum Intercellular Matrix and Lipids

Molecular classification
Other (extracellular matrix lipid domain), ceramides, cholesterol, free fatty acids, sphingolipids
01

Overview

The stratum corneum intercellular matrix and lipids refers not to a single molecular entity, but to a structured extracellular lipid domain within the uppermost layer of the epidermis, crucial for skin barrier function. It is not a discrete receptor, enzyme, or protein target; thus, it is not conventionally considered a therapeutic target in the sense of drug-target interactions as is typical for pharmacologically defined receptors or enzymes. This structure comprises the organized, multi-lamellar, extracellular lipid structure that fills the intercellular spaces between corneocytes (dead, flattened skin cells) in the stratum corneum, the outermost layer of the skin. Major lipid constituents include ceramides, free fatty acids, and cholesterol in approximately equimolar ratios. These lipids are arranged into lamellar bilayers and play an essential role in creating the epidermal permeability barrier, limiting transepidermal water loss and providing protection against external insults and pathogens. Alterations in its composition are implicated in various skin diseases, but the structure as a whole is not a druggable molecular target; instead, therapeutic approaches focus on restoring or supplementing its natural lipid components.

Other names
Stratum corneum lipid matrixSC lipid matrixextracellular lipid matrix of the stratum corneumintercellular lipid lamellae
02

Mechanism of action

Restoration or supplementation of lipid content to improve barrier function; not direct molecular targeting but replacement or enhancement.

03

Biological functions

Barrier formation (preventing water loss and entry of pathogens and chemicals)Maintaining hydration via the barrierSupporting antimicrobial defense
04

Disease associations

Barrier dysfunction in atopic dermatitisBarrier dysfunction in psoriasisBarrier dysfunction in ichthyosisInvolved in xerosis (dry skin)
05

Safety considerations

Skin barrier disruption can increase susceptibility to infections, allergies, and chemical exposure; topical products must avoid further disrupting lipid organizationSome barrier repair products may cause irritation if improperly formulated
06

Interacting drugs

Topical formulations and skin barrier repair treatments (e.g., ceramide-containing creams, emollients)
07

Biomarkers

Changes in lipid profile (ceramides, cholesterol, fatty acids ratios)Transepidermal water loss (TEWL)

Beyond the preview

Go deeper on Stratum Corneum Intercellular Matrix and Lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stratum Corneum Intercellular Matrix and Lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call